ABSTRACT
AIMS: Diabetic neuropathy is associated with increased risk of morbidity and all-cause mortality. It is unclear whether these outcomes differ in patients with diabetic neuropathy treated with pathogenetically oriented vs symptomatic pharmacotherapies.
METHODS: We performed a retrospective (2009-2019) database analysis of patients treated with pathogenetically oriented alpha-lipoic acid (ALA) or symptomatic pharmacotherapies for diabetic neuropathy. We investigated clinical outcomes in propensity score matched patients in Hungary. Changes in hazard ratios and annualized event rates were assessed and sensitivity analyses performed.
RESULTS: Hazard ratios favored treatment with ALA vs symptomatic pharmacotherapies regarding acute myocardial infarction (HR 0.73, 95%CI: 0.60-0.89, p = 0.0016), stroke (HR 0.71, 95%CI: 0.62-0.82, p<0.0001),<0.0001),<0.0001),
CONCLUSIONS: This retrospective database analysis revealed a lower occurrence of cardio- and cerebrovascular morbidity, cancer events and all-cause mortality in patients with diabetic neuropathy treated with pathogenetically oriented ALA vs symptomatic pharmacotherapies. This hypothesis-generating result requires further investigations.
PMID:37257759 | DOI:10.1016/j.diabres.2023.110734
17:26
Photo
Not included, change data exporting settings to download.
1200×1200, 39.0 KB
17:26
Photo
Not included, change data exporting settings to download.
1200×1200, 39.0 KB
17:26
Photo
Not included, change data exporting settings to download.
1200×1200, 39.0 KB
17:26
PubMed articles on: Cardio-Oncology
Natriuretic Peptides, Cardio-Oncology
Anatol J Cardiol. 2023 Jun;27(6):298. doi: 10.14744/AnatolJCardiol.2023.6.
NO ABSTRACT
PMID:37257014 | DOI:10.14744/AnatolJCardiol.2023.6
17:26
PubMed articles on: Cardio-Oncology
AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis
Chem Biol Interact. 2023 May 29;381:110566. doi: 10.1016/j.cbi.2023.110566. Online ahead of print.
No comments:
Post a Comment
اكتب تعليق حول الموضوع